ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

FDA Approval Summary: Axicabtagene Ciloleucel for Second-Line Treatment of Large B-Cell Lymphoma.

Poornima Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.